Research Options:

Week of Expected Pricing 10/4/2021
Company Name EXSCIENTIA LTD
Proposed Ticker EXAI
CUSIP 30223G102
Business Description An artificial intelligence-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Our goal is to change the pharmaceutical industry’s underlying pharmacoeconomic model, what we call "Shifting the Curve", by improving the probability of success, time and cost involved with creating new medicines.
Lead Underwriter Barclays Capital Inc, BofA Securities, Inc, Goldman Sachs & Co. LLC,Morgan Stanley & Co. LLC
Co-Managers N/A
Initial Shares 1,38,50,000
Revised Initial Shares N/A
Initial Price $22.00-$22.00
Revised Price N/A
Final Price $22.00
Final Ticker EXAI

 

 

   
  © 2024 ICE Data Services. All rights reserved.